anmelden
FTSE All-Share
5.570,37
PKT
+30,52
PKT
+0,55
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.11.22 | Rio Tinto Hold | Deutsche Bank AG | |
| 23.11.22 | Glencore Buy | Deutsche Bank AG | |
| 22.11.22 | Vodafone Group Underperform | Credit Suisse Group | |
| 22.11.22 | BAT Neutral | Goldman Sachs Group Inc. | |
| 21.11.22 | HSBC Buy | UBS AG | |
| 21.11.22 | Diageo Buy | Jefferies & Company Inc. | |
| 21.11.22 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.11.22 | HSBC Overweight | Barclays Capital | |
| 18.11.22 | Vodafone Group Equal Weight | Barclays Capital | |
| 16.11.22 | Vodafone Group Buy | Deutsche Bank AG | |
| 16.11.22 | Vodafone Group Buy | UBS AG | |
| 15.11.22 | Vodafone Group Buy | Deutsche Bank AG | |
| 15.11.22 | Vodafone Group Equal Weight | Barclays Capital | |
| 15.11.22 | Vodafone Group Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.11.22 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
| 15.11.22 | Vodafone Group Market-Perform | Bernstein Research | |
| 14.11.22 | Glencore Outperform | Credit Suisse Group | |
| 14.11.22 | AstraZeneca Overweight | Barclays Capital | |
| 11.11.22 | Vodafone Group Hold | Jefferies & Company Inc. | |
| 11.11.22 | GSK Sell | UBS AG | |
| 11.11.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 10.11.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 10.11.22 | National Grid Overweight | JP Morgan Chase & Co. | |
| 10.11.22 | AstraZeneca Neutral | UBS AG | |
| 10.11.22 | National Grid Neutral | UBS AG | |
| 10.11.22 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 10.11.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 10.11.22 | Glencore Buy | Goldman Sachs Group Inc. | |
| 09.11.22 | Vodafone Group Buy | Deutsche Bank AG | |
| 09.11.22 | HSBC Neutral | Credit Suisse Group | |
| 09.11.22 | BP Hold | Jefferies & Company Inc. | |
| 09.11.22 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 08.11.22 | Rio Tinto Buy | Goldman Sachs Group Inc. | |
| 08.11.22 | GSK Equal Weight | Barclays Capital | |
| 08.11.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 07.11.22 | BP Neutral | Credit Suisse Group | |
| 07.11.22 | Unilever Buy | Deutsche Bank AG | |
| 07.11.22 | Shell (ex Royal Dutch Shell) Neutral | Goldman Sachs Group Inc. | |
| 03.11.22 | GSK Neutral | Credit Suisse Group | |
| 03.11.22 | GSK Equal Weight | Barclays Capital |